Literature DB >> 10888638

Genetic diversity among Lassa virus strains.

M D Bowen1, P E Rollin, T G Ksiazek, H L Hustad, D G Bausch, A H Demby, M D Bajani, C J Peters, S T Nichol.   

Abstract

The arenavirus Lassa virus causes Lassa fever, a viral hemorrhagic fever that is endemic in the countries of Nigeria, Sierra Leone, Liberia, and Guinea and perhaps elsewhere in West Africa. To determine the degree of genetic diversity among Lassa virus strains, partial nucleoprotein (NP) gene sequences were obtained from 54 strains and analyzed. Phylogenetic analyses showed that Lassa viruses comprise four lineages, three of which are found in Nigeria and the fourth in Guinea, Liberia, and Sierra Leone. Overall strain variation in the partial NP gene sequence was found to be as high as 27% at the nucleotide level and 15% at the amino acid level. Genetic distance among Lassa strains was found to correlate with geographic distance rather than time, and no evidence of a "molecular clock" was found. A method for amplifying and cloning full-length arenavirus S RNAs was developed and used to obtain the complete NP and glycoprotein gene (GP1 and GP2) sequences for two representative Nigerian strains of Lassa virus. Comparison of full-length gene sequences for four Lassa virus strains representing the four lineages showed that the NP gene (up to 23.8% nucleotide difference and 12.0% amino acid difference) is more variable than the glycoprotein genes. Although the evolutionary order of descent within Lassa virus strains was not completely resolved, the phylogenetic analyses of full-length NP, GP1, and GP2 gene sequences suggested that Nigerian strains of Lassa virus were ancestral to strains from Guinea, Liberia, and Sierra Leone. Compared to the New World arenaviruses, Lassa and the other Old World arenaviruses have either undergone a shorter period of diverisification or are evolving at a slower rate. This study represents the first large-scale examination of Lassa virus genetic variation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888638      PMCID: PMC112216          DOI: 10.1128/jvi.74.15.6992-7004.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products.

Authors:  J C Clegg; S M Wilson; J D Oram
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

3.  Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.

Authors:  S L Ruo; S W Mitchell; M P Kiley; L F Roumillat; S P Fisher-Hoch; J B McCormick
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

4.  Surveillance of Lassa fever in missionaries stationed in West Africa.

Authors:  J D Frame
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

5.  Lassa fever in Onitsha, East Central State, Nigeria in 1974.

Authors:  G S Bowen; O Tomori; H Wulff; J Casals; A Noonan; W G Downs
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

6.  Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela.

Authors:  C F Fulhorst; M D Bowen; R A Salas; G Duno; A Utrera; T G Ksiazek; N M De Manzione; E De Miller; C Vasquez; C J Peters; R B Tesh
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

7.  Sequence analysis of the small RNA segment of guinea pig-passaged Pichinde virus variants.

Authors:  L Zhang; K Marriott; J F Aronson
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

8.  Molecular organization of Junin virus S RNA: complete nucleotide sequence, relationship with other members of the Arenaviridae and unusual secondary structures.

Authors:  P D Ghiringhelli; R V Rivera-Pomar; M E Lozano; O Grau; V Romanowski
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

9.  Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region.

Authors:  S M Wilson; J C Clegg
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

10.  Sequence of the nucleocapsid protein gene of Machupo virus: close relationship with another South American pathogenic arenavirus, Junín.

Authors:  C M Griffiths; S M Wilson; J C Clegg
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more
  114 in total

1.  Rapid and specific detection of Lassa virus by reverse transcription-PCR coupled with oligonucleotide array hybridization.

Authors:  Stephan Olschläger; Stephan Günther
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

2.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

3.  Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification.

Authors:  Aiko Fukuma; Yohei Kurosaki; Yuko Morikawa; Allen Grolla; Heinz Feldmann; Jiro Yasuda
Journal:  Microbiol Immunol       Date:  2011-01       Impact factor: 1.955

4.  Current molecular epidemiology of Lassa virus in Nigeria.

Authors:  Deborah U Ehichioya; Meike Hass; Beate Becker-Ziaja; Jacqueline Ehimuan; Danny A Asogun; Elisabeth Fichet-Calvet; Katja Kleinsteuber; Michaela Lelke; Jan ter Meulen; George O Akpede; Sunday A Omilabu; Stephan Günther; Stephan Olschläger
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

5.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.

Authors:  Kristian G Andersen; B Jesse Shapiro; Christian B Matranga; Rachel Sealfon; Aaron E Lin; Lina M Moses; Onikepe A Folarin; Augustine Goba; Ikponmwonsa Odia; Philomena E Ehiane; Mambu Momoh; Eleina M England; Sarah Winnicki; Luis M Branco; Stephen K Gire; Eric Phelan; Ridhi Tariyal; Ryan Tewhey; Omowunmi Omoniwa; Mohammed Fullah; Richard Fonnie; Mbalu Fonnie; Lansana Kanneh; Simbirie Jalloh; Michael Gbakie; Sidiki Saffa; Kandeh Karbo; Adrianne D Gladden; James Qu; Matthew Stremlau; Mahan Nekoui; Hilary K Finucane; Shervin Tabrizi; Joseph J Vitti; Bruce Birren; Michael Fitzgerald; Caryn McCowan; Andrea Ireland; Aaron M Berlin; James Bochicchio; Barbara Tazon-Vega; Niall J Lennon; Elizabeth M Ryan; Zach Bjornson; Danny A Milner; Amanda K Lukens; Nisha Broodie; Megan Rowland; Megan Heinrich; Marjan Akdag; John S Schieffelin; Danielle Levy; Henry Akpan; Daniel G Bausch; Kathleen Rubins; Joseph B McCormick; Eric S Lander; Stephan Günther; Lisa Hensley; Sylvanus Okogbenin; Stephen F Schaffner; Peter O Okokhere; S Humarr Khan; Donald S Grant; George O Akpede; Danny A Asogun; Andreas Gnirke; Joshua Z Levin; Christian T Happi; Robert F Garry; Pardis C Sabeti
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

Review 6.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

7.  Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  M Djavani; C Yin; I S Lukashevich; J Rodas; S K Rai; M S Salvato
Journal:  J Hum Virol       Date:  2001 Mar-Apr

8.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

Review 9.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

Authors:  Ricardo Carrion; Peter Bredenbeek; Xiaohong Jiang; Irina Tretyakova; Peter Pushko; Igor S Lukashevich
Journal:  J Vaccines Vaccin       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.